Skip to Main Content

After decades of attempts to develop treatments for Alzheimer’s disease, scientists still have precious little to show for it. Now, after some high-profile failures, there are big questions about where researchers can turn next.

Join STAT senior science writer Sharon Begley and STAT senior medicine writer Matt Herper for a subscriber-only live chat on Alzheimer’s research, the beta-amyloid theory, and the effort to develop new therapies. They’ll also be discussing the latest news out of the Alzheimer’s Association International Conference.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!